• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[米耶罗皮德在浸润型肺结核患者综合治疗中的应用]

[Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].

作者信息

Vakhidova G A, Vasil'eva F R, Kurbanova R R, Stepanenko R N, Ubaĭdullaev A M

出版信息

Probl Tuberk. 1990(3):16-8.

PMID:2367502
Abstract

A complex immunotherapy regimen containing myelopid in combination with chemotherapeutic drugs was prescribed for 30 patients aged from 17 to 54 years and suffering from destructive pulmonary tuberculosis. It was proved that a complex treatment favored the normalization of the main immunologic indices, thus greatly increasing the efficacy of pulmonary tuberculosis patient management.

摘要

为30名年龄在17至54岁之间、患有破坏性肺结核的患者制定了一种包含髓吡多与化疗药物联合使用的复杂免疫治疗方案。事实证明,综合治疗有助于主要免疫指标恢复正常,从而大大提高了肺结核患者的治疗效果。

相似文献

1
[Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].[米耶罗皮德在浸润型肺结核患者综合治疗中的应用]
Probl Tuberk. 1990(3):16-8.
2
[T- and b systems of immunity in patients with newly detected destructive pulmonary tuberculosis during complex therapy].
Probl Tuberk. 1981 Feb(2):24-8.
3
[Effectiveness of antitubercular chemotherapy combined with corticosteroids and immunomodulators].抗结核化疗联合皮质类固醇和免疫调节剂的疗效
Probl Tuberk. 1990(1):24-8.
4
[Effectiveness of administration of thymalin in the complex treatment of pulmonary tuberculosis].
Probl Tuberk. 1990(10):29-32.
5
[Prevention of side effects of specific chemotherapy in patients with pulmonary tuberculosis].[预防肺结核患者特定化疗的副作用]
Probl Tuberk. 1991(7):60-2.
6
[Blood T-lymphocyte functional activity in pulmonary tuberculosis patients undergoing chemotherapeutic agent and vitamin treatment].
Probl Tuberk. 1982 Mar(3):47-50.
7
[Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].[糖尿病患者肺结核细胞免疫的特异性特征]
Probl Tuberk. 1997(6):59-60.
8
[Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].[浸润性和播散性肺结核患者的继发性免疫缺陷及其骨髓系纠正]
Probl Tuberk. 1998(2):20-2.
9
[Changes in the functional activity of blood lymphocytes in patients with destructive pulmonary tuberculosis during the treatment].[破坏性肺结核患者治疗期间血液淋巴细胞功能活性的变化]
Probl Tuberk. 1991(10):63-6.
10
[Tactivin in combined treatment of patients with pulmonary tuberculosis associated with gastrointestinal diseases].[促活素在合并胃肠道疾病的肺结核患者联合治疗中的应用]
Probl Tuberk. 1995(3):25-7.